The analysis found that: At 12 months, Omada members largely maintained their weight at GLP-1 discontinuation, with an average 0.8% weight change At 12 months, 63.2% of members maintained or continued to lose weight At 6 and 9 months, Omada members demonstrated 0.03% and 0.6% average weight change, respectively These findings suggest that Omada can play an integral role in supporting members during important transitions in their GLP-1 journey, including helping members maintain their weight well after GLP-1 discontinuation.
Embrace the journey Well walk with you each weekthrough email check-ins, monthly visits, and anytime you need help
For someone starting at 250 pounds, 30 pounds is 12%, which is well within reach on a mid-range dose
Neither men nor women should rush the dose escalation
I think it emphasizes the importance of [matching] treatment to the right patient and making sure that we, as clinicians, really counsel patients about what to expect and how to reduce their risk of having those side effects. Both pills target GLP-1 receptors in the body to increase insulin secretion and satiety levels
